Triapine (3-AP)

3-aminopyridine-2-one

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Triapine (3-AP), covering 2013-05-15 to 2013-11-06. Get the full timeline:

Most recent: Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]